circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway

Glioblastoma has been identified as the most common and aggressive primary brain tumor in adults. Recently, it has been found that cisplatin (DDP) treatment is a common chemotherapeutic method for GBM patients. circ_PTN (ID number: hsa_circ_0003949) is a newly found circular (circRNA) which has been...

詳細記述

書誌詳細

主要な著者:	Hongcheng Luo, Tingzhuang Yi, Deyou Huang, Xiaoping Chen, Xu Li, Qianquan Wan, Haineng Huang, Huadong Huang, Hongyu Wei, Ye Song, Tianshi Que, Rentong Hu, Huatuo Huang, Kunxiang Luo, Chuanyu Li, Chengjian Qin, Chuanhua Zheng, Chuanliu Lan, Wencheng Chen, Dan Zhou, Qisheng Luo
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2021-12-01
シリーズ:	Molecular Therapy: Nucleic Acids
主題:	circ_PTN miR-542-3p PIK3R3 cisplatin-resistance glioblastoma PI3K/AKT signaling
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2162253121002298
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!